Moderna’s LP.8.1-adapted COVID-19 vaccine has been recommended by the European Medicines Agency (EMA)’s human medicines ...

The European Union's drug regulator has recommended approval of Moderna's updated formulation of COVID-19 shot Spikevax, the ...

Shuhiba Mohammad recently took her daughter for her routine childhood immunizations at age 1, and was frustrated when she was ...

Moderna will keep its COVID vaccine on the market at no cost to consumers, even after the federal government stops paying for it, the company announced Wednesday. "Everyone in the United States ...

MRNA's second-quarter results are likely to spotlight a sharp decline in Spikevax sales, RSV uptake and key pipeline ...

Moderna is seeking emergency use authorization from the US Food and Drug Administration for its Covid-19 vaccine for children 6 months through 5 years of age, the company said Thursday.

COVID vaccine maker Pfizer Inc. lost 0.6%, while its partner BioNTech, shed 3.8%. Moderna’s latest efficacy data hasn’t been published in a medical journal and further details weren’t released.

Moderna's trial of a new COVID-19 vaccine will target the virus variant that first emerged in South Africa. Other vaccine makers plan similar studies.

Moderna’s Covid Vaccine: What You Need to Know Denise Grady Published Nov. 16, 2020 Updated Nov. 30, 2020 Share full article ...

Moderna's candidate COVID-19 vaccine is even more effective than Pfizer's, trial results show, a "light at the end of the tunnel" for the pandemic.

Moderna's COVID-19 Vaccine Shines In Clinical Trial Overall, the study identified 185 cases in the people who received a placebo shot, compared with 11 cases in people who got the active vaccine.